In individuals with overweight or obesity, treatment with semaglutide was associated with significant reductions in bodyweight, with a mean placebo-subtracted weight loss of 12.4% relative to placebo after 68 weeks reported in the STEP 1 trial
Barriers to Access and Adherence: Only 1 in 10 Receives MAT Why do only about 1 in 10 people with OUD get MAT
Two popular treatments for chronic joint pain are stem cell treatment and platelet-rich plasma (PRP) therapy
Unlike other OATP transporters, OATP1A2 possesses perhaps the broadest spectrum of solutes in that compounds of acidic, basic, and neutral character are substrates
Cagrilintide + semaglutide yielded 17.1% weight loss compared to 9.8% with semaglutide alone
The 30-second verdict on at-home microinfusion molecules The honest answer most skincare guides won't give you: at-home microinfusion is one of the few cosmetic categories where the underlying biology genuinely changes when the delivery technology changes